Establishment Labs (ESTA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
28 May, 2026Opening remarks and agenda
Meeting called to order virtually with all board members and key executives present.
Introduction of directors, CFO, General Counsel, and independent auditors.
Shareholders welcomed and informed about the virtual Q&A process.
Board and executive committee updates
Six directors nominated for election to serve one-year terms.
Shareholder proposals
Three proposals presented: election of directors, advisory vote on executive compensation, and ratification of independent auditors.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Establishment Labs
- 2025 guidance targets $205–$210M revenue, EBITDA positive, and rapid US-driven growth.ESTA
Investor Day 20259 Jul 2026 - Rapid U.S. growth, premium pricing, and innovation set the stage for market dominance and expansion.ESTATD Cowen 46th Annual Health Care Conference8 Jul 2026
- Q4 revenue up 45%, gross margin at 70.5%, and 2026 revenue growth guided above 25%.ESTAQ4 20258 Jul 2026
- Q1 revenue up 45% year-over-year, gross margin at 70.7%, and 2026 guidance raised.ESTAQ1 20268 May 2026
- Director compensation figures were corrected, and additional equity awards disclosed for consulting roles.ESTAProxy filing24 Apr 2026
- Virtual meeting to elect directors, approve pay, and ratify auditor, with strong governance focus.ESTAProxy filing10 Apr 2026
- Vote on directors, executive pay, and auditor ratification at the May 2026 annual meeting.ESTAProxy filing10 Apr 2026
- Q2 revenue rose 18.7% sequentially; FDA approval for Motiva Implants expected soon.ESTAQ2 20242 Feb 2026
- Innovation, global expansion, and regulatory progress position the company for rapid growth.ESTAGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026